Final Prospectus Filed for Resale of 545,456 Shares from Series A Preferred Stock, Deeply Dilutive to Existing Holders

summarizeSummary

Movano Inc. filed the final prospectus for the resale of 545,456 common shares by selling stockholders, originating from a Series A Preferred Stock financing at an effective price of $5.50 per share, with the company receiving no proceeds.

check_boxKey Events

• Finalizes Resale Offering

  This 424B7 filing finalizes the terms for the resale of 545,456 common shares by selling stockholders, stemming from a Series A Preferred Stock financing initiated on November 6, 2025.

• Significant Potential Dilution

  The 545,456 shares represent approximately 32.3% of Movano's outstanding common stock and 43.2% of the non-affiliate voting power, posing substantial selling pressure.

• Deep Discount Pricing

  The shares are issuable upon conversion of Series A Preferred Stock at an effective price of $5.50 per share, significantly below the current market price of $11.27.

• No Proceeds to Company

  Movano Inc. will not receive any proceeds from the sale of these shares by the selling stockholders.

auto_awesomeAnalysis

This 424B7 filing is highly significant as it finalizes the terms for the resale of a substantial block of Movano Inc. common stock by selling stockholders, originating from a Series A Preferred Stock financing. The 545,456 shares, convertible at an effective price of $5.50 per share (a deep discount to the current market price of $11.27), represent a considerable portion of the company's outstanding shares and non-affiliate voting power. Crucially, Movano Inc. will not receive any proceeds from this resale, meaning it does not bolster the company's financial position. This event is particularly impactful given the ongoing reverse merger with Corvex, Inc., which is already set to heavily dilute existing Movano shareholders. The additional selling pressure from these deeply discounted shares, combined with the company's existing Nasdaq non-compliance issues, signals significant financial distress and potential further downward pressure on the stock. Investors should be aware of the substantial dilution and the lack of capital infusion for the company from this specific offering.